Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common stock, $0.00001 par value per share
-
Shares outstanding
-
60,389,334
-
Total 13F shares
-
65,889,652
-
Share change
-
-219,187
-
Total reported value
-
$2,978,632,352
-
Put/Call ratio
-
32%
-
Price per share
-
$45.18
-
Number of holders
-
239
-
Value change
-
-$19,242,374
-
Number of buys
-
116
-
Number of sells
-
123
Institutional Holders of Twist Bioscience Corp - Common stock, $0.00001 par value per share (TWST) as of Q3 2024
As of 30 Sep 2024,
Twist Bioscience Corp - Common stock, $0.00001 par value per share (TWST) was held by
239 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
65,889,652 shares.
The largest 10 holders included
Artisan Partners Limited Partnership, VANGUARD GROUP INC, BlackRock, Inc., ARK Investment Management LLC, Invesco Ltd., WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, STATE STREET CORP, Sumitomo Mitsui Trust Group, Inc., Nikko Asset Management Americas, Inc., and JPMORGAN CHASE & CO.
This page lists
240
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.